Performance of PLRX Pliant Therapeutics Inc | -30.1% in 12m
Compare PLRX with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Pliant Therapeutics Inc with its related Sector/Index XBI
Performance Duell PLRX vs XBI
| TimeFrame | PLRX | XBI |
|---|---|---|
| 1 Day | -2.18% | -1.52% |
| 1 Week | 11.7% | 1.45% |
| 1 Month | 22.0% | 10.08% |
| 3 Months | -1.80% | -1.30% |
| 6 Months | 6.34% | 24.09% |
| 12 Months | -30.1% | 6.83% |
| YTD | -15.0% | 1.05% |
| Rel. Perf. 1m | 1.00 | |
| Rel. Perf. 3m | -2.17 | |
| Rel. Perf. 6m | -1.47 | |
| Rel. Perf. 12m | -4.43 |
Is Pliant Therapeutics Inc a good stock to buy?
Probably not. Based on ValueRay Analyses, Pliant Therapeutics Inc (NASDAQ:PLRX) is currently (May 2024)
not a good stock to buy. It has a ValueRay Growth Rating of -2.96 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PLRX as of May 2024 is 13.02. This means that PLRX is currently overvalued and has a potential downside of -14.73% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PLRX as of May 2024 is 13.02. This means that PLRX is currently overvalued and has a potential downside of -14.73% (Sold with Premium).
Is PLRX a buy, sell or hold?
- Strong Buy: 9
- Buy: 5
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: PLRX is performing better - Values below 0%: PLRX is underperforming
Compare PLRX with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.06% | 15.03% | -11.05% | -58.39% |
| US NASDAQ 100 | QQQ | 9.74% | 13.01% | -9.72% | -65.23% |
| US Dow Jones Industrial 30 | DIA | 10.31% | 16.50% | -8.44% | -51.99% |
| German DAX 40 | DBXD | 11.94% | 16.81% | -10.82% | -44.46% |
| UK FTSE 100 | ISFU | 10.16% | 12.41% | -9.90% | -44.73% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 10.55% | 17.23% | 4.22% | -22.80% |
| Hongkong Hang Seng | HSI | 9.55% | -0.90% | 2.65% | -24.67% |
| Japan Nikkei 225 | EXX7 | 10.64% | 21.08% | -5.44% | -40.81% |
| India NIFTY 50 | INDA | 9.28% | 18.76% | -11.24% | -59.90% |
| Brasil Bovespa | EWZ | 11.79% | 18.67% | 10.10% | -42.79% |
PLRX Pliant Therapeutics Inc vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.51% | 18.01% | -10.84% | -65.86% |
| Consumer Discretionary | XLY | 11.23% | 16.69% | -0.45% | -48.91% |
| Consumer Staples | XLP | 10.65% | 16.90% | -7.98% | -36.11% |
| Energy | XLE | 10.23% | 21.97% | -7.62% | -53.44% |
| Financial | XLF | 9.71% | 16.73% | -15.59% | -62.74% |
| Health Care | XLV | 9.71% | 16.66% | -7.97% | -43.33% |
| Industrial | XLI | 11.56% | 17.93% | -12.99% | -57.79% |
| Materials | XLB | 11.30% | 18.37% | -9.48% | -49.68% |
| Real Estate | XLRE | 9.46% | 13.93% | -2.46% | -40.94% |
| Technology | XLK | 9.13% | 11.94% | -8.32% | -65.68% |
| Utilities | XLU | 10.20% | 11.40% | -12.22% | -43.27% |
| Aerospace & Defense | XAR | 10.63% | 13.60% | -7.91% | -54.51% |
| Biotech | XBI | 10.25% | 11.88% | -17.75% | -36.91% |
| Homebuilder | XHB | 11.12% | 14.96% | -23.92% | -80.93% |
| Retail | XRT | 12.18% | 15.27% | -13.76% | -59.58% |
Does Pliant Therapeutics Inc outperform its market, is PLRX a Sector Leader?
No, over the last 12 months Pliant Therapeutics Inc (PLRX) made -30.08%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months PLRX made -1.80%, while XBI made -1.30%.
No, over the last 12 months Pliant Therapeutics Inc (PLRX) made -30.08%, while its related Sector, the SPDR S&P Biotech (XBI) made 6.83%.
Over the last 3 months PLRX made -1.80%, while XBI made -1.30%.
| Period | PLRX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 21.96% | 10.08% | 6.93% |
| 3 Months | -1.80% | -1.30% | 6.91% |
| 12 Months | -30.08% | 6.83% | 28.31% |